Search Within

David J Straus

Formats
  1. Meeting Abstract (168)
  2. Journal Article (166)
  3. Book Section (15)
  4. Conference Paper (5)
  5. Research Letter (3)
  6. Editorial (2)
  7. Correspondence (1)
  8. Review (1)
Groups
  1. Center for Hematologic Malignancies (361)
  2. Department of Medicine (361)
  3. Hematologic Malignancies, Division of (361)
  4. Lymphoma (361)
  5. Survivorship Research (162)
  6. Population Sciences Research Program (129)

More Groups

People
  1. Andrew Zelenetz (163)
  2. Ariela Noy (139)
  3. Paul Hamlin (122)
  4. Steven Horwitz (122)
  5. Craig Moskowitz (117)
  6. Matthew Matasar (104)

More People

Years
  1. 2024 (10)
  2. 2023 (9)
  3. 2022 (13)
  4. 2021 (27)
  5. 2020 (25)
  6. 2019 (21)

More Years

Publications
  1. Blood (117)
  2. Journal of Clinical Oncology (44)
  3. Hematological Oncology (19)
  4. Cancer (14)
  5. Leukemia and Lymphoma (13)
  6. British Journal of Haematology (11)

More Publications

Publishers
  1. American Society of Hematology (124)
  2. American Society of Clinical Oncology (46)
  3. Wiley Blackwell (36)
  4. Elsevier Inc. (23)
  5. Taylor & Francis Group (14)
  6. John Wiley & Sons (12)

More Publishers

Results (361)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II, multicenter study of high dose chemotherapy with autologous stem cell transplant followed by maintenance therapy with romidepsin for T-cell lymphoma
    Meeting Abstract

    Khan, N.; Shustov, A. R.; Khimani, F.; Shadman, M.; Cassaday, R. D.; Ruan, J.; Moskowitz, A. J.; Zelenetz, A. D.; Noy, A.; Straus, D. J.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Contemporary outcomes in HTLV-1-associated adult T-cell leukemia/lymphoma: Single-institution experience
    Meeting Abstract

    Epstein-Peterson, Z. D.; Ghione, P.; Moskowitz, A. J.; Dahi, P. B.; Dogan, A.; Kumar, A.; Matasar, M. J.; Noy, A.; Perales, M. A.; Ponce, D. M.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Brentuximab vedotin with chemotherapy for Stage 3/4 classical Hodgkin lymphoma (cHL): 4-year update of the ECHELON-1 study
    Meeting Abstract

    Bartlett, N. L.; Straus, D. J.; Dlugosz-Danecka, M.; Alekseev, S.; Illes, A.; Lech-Maranda, E.; Feldman, T. A.; Smolewski, P.; Savage, K. J.; Walewski, J.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Central nervous system prophylaxis with high-dose intravenous methotrexate or intrathecal chemotherapy in patients with diffuse large B-cell lymphoma and high-risk of CNS relapse treated in the rituximab era
    Meeting Abstract

    Bobillo, S.; Joffe, E.; Seshan, V.; Noy, A.; Horwitz, S. M.; Palomba, M. L.; Matasar, M. J.; Straus, D. J.; Hamlin, P. A.; Batlevi, C. L.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Genomic profiling of mantle cell lymphoma suggests poor-risk profile is present at diagnosis and does not arise by tumor evolution
    Meeting Abstract

    Joffe, E.; Kumar, A.; Zheng, S.; Uppal, M.; Bantilan, K. S.; Atteberry, P.; Straus, D. J.; Palomba, M. L.; Noy, A.; Horwitz, S. M.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Genomic profiling of mantle cell lymphoma suggests poor-risk profile is present at diagnosis and does not arise by tumor evolution
    Meeting Abstract

    Joffe, E.; Kumar, A.; Zheng, S.; Uppal, M.; Bantilan, K. S.; Atteberry, P.; Straus, D. J.; Palomba, M. L.; Noy, A.; Horwitz, S. M.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Five-year follow-up of SWOG S0816: Limitations and values of a PET-adapted approach with stage III/IV Hodgkin lymphoma
    Journal Article

    Stephens, D. M.; Li, H.; Schöder, H.; Straus, D. J.; Moskowitz, C. H.; LeBlanc, M.; Rimsza, L. M.; Bartlett, N. L.; Evens, A. M.; LaCasce, A. S.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Brentuximab vedotin with chemotherapy for stage 3/4 classical Hodgkin lymphoma: Three-year update of the ECHELON-1 study
    Meeting Abstract

    Straus, D. J.; Dlugosz-Danecka, M.; Alekseev, S.; Illes, A.; Picardi, M.; Lech-Maranda, E.; Feldman, T.; Savage, K. J.; Smolewski, P.; Bartlett, N. L.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Incidence and treatment outcomes of patients with transformed marginal zone lymphoma treated with RCHOP‐like regimens
    Meeting Abstract

    Rajeeve, S.; Bobillo, S. V.; Zelenetz, A. D.; Straus, D. J.; Palomba, M. L.; Noy, A.; Horwitz, S. M.; Moskowitz, A. J.; Hamlin, P. A.; Matasar, M. J.; more...
    Hematological Oncology (2019)

    Fulltext@MSK | Save
  • Clinical characteristics and outcomes of stage I diffuse large B cell lymphoma (DLBCL) in the rituximab‐era
    Meeting Abstract

    Bobillo, S.; Joffe, E.; Lavery, J.; Noy, A.; Palomba, L.; Straus, D. J.; Kumar, A.; Batlevi, C.; Horwitz, S.; Moskowitz, A.; more...
    Hematological Oncology (2019)

    Fulltext@MSK | Save